Roosen J U, Larsen T, Iversen E, Berg J B
Department of Surgery, Frederikssund Sygehus, Denmark.
Br J Urol. 1991 Oct;68(4):404-6. doi: 10.1111/j.1464-410x.1991.tb15361.x.
Of 98 hydroceles (mean volume 125 ml) in a consecutive series of 92 patients, treated initially by aspiration, 14% (mean volume 70 ml) were cured. The 76 recurring hydroceles (mean volume 146 ml) were then randomised to either antazoline sclerotherapy on an out-patient basis or surgery. Cure rates were 89 and 100%, respectively, at follow-up 6 months later. Operated patients were admitted for a mean duration of 2.5 days. The results indicated that aspiration alone was inadequate, and sclerotherapy is advocated as the first choice of treatment for hydrocele.
在连续92例患者的98个鞘膜积液（平均体积125毫升）中，最初采用抽吸治疗，14%（平均体积70毫升）得到治愈。然后将76个复发的鞘膜积液（平均体积146毫升）随机分为门诊接受安他唑啉硬化治疗或手术治疗。6个月后的随访显示，治愈率分别为89%和100%。接受手术的患者平均住院时间为2.5天。结果表明，单纯抽吸治疗不足，硬化治疗被推荐为鞘膜积液的首选治疗方法。
